Ensysce Biosciences, Inc. ENSC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Ensysce Biosciences, Inc. (ENSC) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist HG Vora Capital Management, LLC mit 3,837,500 Aktien. Weitere bedeutende Anteilseigner sind Silvers Daniel B. und GOWER BOB G.

ENSC Insider-Beteiligungen

Größter Aktionär

HG Vora Capital Management, LLC

3,837,500 Aktien

Käufe (12 Monate)

$0.00 Wert

Verkäufe (12 Monate)

$0.00 Wert

Top-Insider-Aktionäre

#	Name	Funktion	Gehaltene Aktien	Zuletzt gemeldet	Relative Größe
1	Hg Vora Capital Management, Llc	10 Percent Owner	3,837,500	2018-01-17	100%
2	Silvers Daniel B.	10 Percent Owner	1,637,390	2021-07-01	43%
3	Gower Bob G	Director	1,222,682	2023-03-06	32%
4	Kirkpatrick Lynn	Chief Executive Officer	381,851	2022-05-27	10%
5	Pestano Linda	Chief Development Officer	200,000	2022-02-04	5%
6	Weil A Lorne	10 Percent Owner	137,895	2021-07-01	4%
7	Benton Andrew	Director	100,850	2022-06-27	3%
8	Martin Steven Robert	Director	100,850	2022-06-27	3%
9	Humphrey David Carl	Chief Financial Officer	80,000	2022-02-24	2%
10	Schmidt William K	Chief Medical Officer	69,142	2021-07-02	2%
11	Birkett Kevin Geoffrey	Chief Commercial Officer	50,000	2022-02-24	1%
12	Levin Adam	Director	35,000	2022-06-27	1%
13	Chang William H	Director	35,000	2022-06-27	1%
14	Rauch Lee M.	Director	35,000	2022-06-27	1%
15	Rosebraugh Curtis	Director	35,000	2022-06-27	1%
16	Carrera Eric	Officer	30,000	2021-07-01	1%
17	Rittvo Steven M	Director	25,000	2017-12-01	1%
18	Weinstein David L.	Director	25,000	2017-12-01	1%
19	Falcone Marc J.	Director	25,000	2017-12-01	1%
20	Wright Richard Chester	Chief Business Officer	19,755	2021-07-02	1%